BTIS
EW icon

BB&T Investment Services’s Edwards Lifesciences EW Stock Holding History

BB&T Investment Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$66K Buy
1,734
+213
+14% +$7.82K 0.01% 510
2017
Q3 		$56K Buy
1,521
+219
+17% +$8.35K 0.01% 502
2017
Q2 		$50K Buy
1,302
+456
+54% +$16.6K 0.01% 470
2017
Q1 		$25K Buy
846
+492
+139% +$15.4K 0.01% 518
2016
Q4 		$11K Buy
+354
New +$11.5K 0.01% 502

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BB&T Investment Services's EW Position: Q4 2017 in Review

BB&T Investment Services increased its Edwards Lifesciences (EW) stake by 14% in Q4 2017, buying an estimated $7.82K and bringing the position to 1,734 shares worth $66K. The position accounts for 0.01% of the portfolio, ranked #510.

BB&T Investment Services first reported a position in EW in Q4 2016 and has held it in 5 quarters since. 773 funds tracked by Wall St. Rank hold EW as of Q4 2017.

  • BB&T Investment Services held 1,734 shares of Edwards Lifesciences worth $66K as of Q4 2017.
  • BB&T Investment Services bought 213 Edwards Lifesciences shares in Q4 2017, an estimated $7.82K.
  • Edwards Lifesciences made up 0.01% of BB&T Investment Services's portfolio in Q4 2017, its #510 holding.
  • BB&T Investment Services first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 5 quarters since.
  • 773 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.